Taking drugs like LSD and ecstasy can increase your risk of schizophrenia, according to new study
Psychedelics have been growing in popularity across North America for recreational and therapeutic use, with celebrities like ...
HealthDay on MSN7h
FDA Approves Cobenfy for Adults With Schizophrenia
The U.S. Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic ...
Honolulu Star-Advertiser16h
Pearl City man who allegedly stabbed father reportedly stopped medication
A 61-year-old man allegedly stabbed Sunday night by his 26-year-old son in Pearl City told police his son suffers from ...
The Manhattan Mercury2d
Psychedelics Like Psilocybin, MDMA Tied to Higher Odds for Schizophrenia
Even after controlling for a person’s existing substance use and mental health disorders, there remained a 3.5-fold increased ...
BioPharma Dive3d
On Wall Street, ‘flat out’ failure of AbbVie schizophrenia drug leaves analysts stunned
Negative data cost AbbVie billions of dollars in market value and convinced analysts Bristol Myers had placed a better bet in ...
BioPharma Dive3d
AbbVie’s $9B bet collapses as closely watched schizophrenia drug fails studies
Shares in AbbVie slumped Monday after the company disclosed its psychiatric medicine emraclidine didn’t best placebo in two ...
Ottawa Citizen on MSN1d
Study finds 'concerning link' between hospital visits for psychedelic use and schizophrenia
The research, led by Dr. Daniel Myran, a Canada Research Chair in Social Accountability at the University of Ottawa, followed ...
AbbVie Tumbles After New Schizophrenia Drug Fails Two Trials
AbbVie Inc. shares fell the most in more than four years after two mid-stage trials of its drug to treat schizophrenia failed ...
Psychedelic use linked to increased risk of schizophrenia, study finds
Individuals with emergency department visits involving hallucinogen use are at high risk of developing schizophrenia, ...
technologynetworks1d
Schizophrenia Risk Rises After Hallucinogen-Related ER Visits
A new study from ICES and University of Ottawa reveals a 21-fold increase in schizophrenia risk following emergency visits ...
MedCity News4d
AbbVie Drug Expected to Rival Bristol Myers’s New Schizophrenia Med Flunks Phase 2 Test
Many currently available schizophrenia drugs work by blocking dopamine type 2 (D2) receptors. But these drugs offer limited efficacy while introducing side effects that make it hard for patients ...